Trinity College spinout Genable Technologies has been acquired by US gene therapy giant Spark Therapeutics for €5.4m and 265,000 shares. Genable – which makes gene-based drugs that treat genetic ...
Genable has announced that it has completed a transaction which will see it become fully owned by Spark Therapeutics. Annette Clancy, Chair of the Board of Directors of Genable commented “We are ...
Spark Adds New Program for One of the Leading Causes of Inherited Retinal Disease, Broadening Its Pipeline of Potential Treatments for Rare Blinding Conditions "This transaction advances our strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results